Read More Pharma Industry News Cancer Targeted Technology gets NIH grant to support CTT1403 trial Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US… bypharmanewsdailyAugust 7, 2020